82 results
10-K
2023 FY
EX-10.12
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
.......................................................................................................... 41 10.5 Audit Rights … and stability testing, assay development and audit development, toxicology, formulation, quality assurance/quality control development, technical development
10-K
2023 FY
EX-31.1
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing
10-K
2023 FY
EX-31.2
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
material weaknesses in such controls. In connection with the audit of our financial statements for the year ended December 31, 2023, we have identified … Listing Rule 5610.
In accordance with our Nasdaq listing, our audit committee is required to comply with the provisions of Section 301
8-K
AUTL
Autolus Therapeutics plc
21 Mar 24
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:21pm
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit … of research and development expense, rather than income tax expense. On March 15, 2024, the Audit Committee of the Company’s Board of Directors, upon
8-K
EX-1.1
y9p3o al35r0cc7htll
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
8-K
EX-10.1
e89bcfui gsriy3tqbip
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
8-K
5bg6 bggy01
22 Dec 23
Departure of Directors or Certain Officers
8:24am
10-Q
EX-31.1
rkprmjrqn72z
9 Nov 23
Quarterly report
4:18pm
10-Q
oqo5 khjf
9 Nov 23
Quarterly report
4:18pm
10-Q
EX-31.2
p537mp1o1wzo7v
9 Nov 23
Quarterly report
4:18pm
6-K
EX-99.2
e677czzwztdc
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
6-K
EX-99.2
5ormg fkt8b
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K/A
EX-99.2
0w4p1xa
6 Jul 23
Current report (foreign) (amended)
5:38pm
6-K
EX-99.2
93qu2to2v
6 Jun 23
Current report (foreign)
8:18am
6-K
EX-99.2
nk3wa rbg44iims3t
4 May 23
Index to Condensed Consolidated Financial Statements
4:04pm
6-K
EX-1.1
d4wy fubh38dmjj0b
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
6-K/A
EX-99.2
vzi6d58 er
21 Nov 22
Current report (foreign) (amended)
4:03pm
6-K
EX-99.2
tq9aimdbsg02q
3 Nov 22
Index to Condensed Consolidated Financial Statements
10:31am
6-K
EX-99.2
2ue3v12a jf3nl
4 Aug 22
Index to Condensed Consolidated Financial Statements
4:06pm